Antipsychotic Drugs Market In United States

Antipsychotic Drugs Market Size to Reach USD 24.74 Million by 2029

The recently released Fortune Business Insights research on the Global Antipsychotic Drugs Market survey report provides facts and statistics regarding market structure and size. Global Antipsychotic Drugs Market Trends Research report presents an in-depth analysis of the Antipsychotic Drugs Market size, growth, share, segments, manufacturers, and forecast, competition landscape and growth opportunity. The research’s goal is to provide market data and strategic insights to help decision-makers make educated investment decisions while also identifying potential gaps and development possibilities.

Regional Insights

Rapid Shift Towards Advanced and Safe Drugs to Favor Growth in North America

Geographically, the global antipsychotic drugs market is grouped into Latin America, Asia Pacific, North America, the Middle East and Africa, and Europe. Amongst these regions, North America had acquired US$ 9,307.3 Mn antipsychotic drugs market revenue in the year 2018. The growth is attributed to the increasing patient pool suffering from psychotic disorders in the region.

Additionally, a rapid shift of these patients towards safe antipsychotic drugs for the treatment of schizophrenia, bipolar disorder, and other psychotic diseases is expected to drive the antipsychotic drugs market in this region. Several healthcare organizations in North America have also begun promoting such drugs for treatment.

In Asia Pacific, emerging countries, such as India, China, and other Southeast Asian countries have a large patient pool who are suffering from various disorders, especially schizophrenia. Moreover, the populace residing in these countries are preferring second-generation drugs over first-generation antipsychotic drugs. It is because of the increasing healthcare expenditure and increasing awareness programs regarding the usage of these drugs. Fortune Business Insights predicts that Europe would follow the footsteps of North America and would remain in the second position throughout the forecast period. The growth is attributed to a rise in the patient population and increasing incidence of psychotic diseases.

Get Sample PDF Brochure: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/101390

Fortune Business Insights has profiled some of the prominent market players operating in the global antipsychotic drugs market. They are as follows:

• H. Lundbeck A/S

• Otsuka Pharmaceutical Co., Ltd.

• Janssen Pharmaceuticals, Inc.

• Eli Lilly and Company

• AstraZeneca

• ALLERGAN

• Vanda Pharmaceuticals Inc.

• Sumitomo Dainippon Pharma Co., Ltd.

• Alkermes plc

• Pfizer Inc.

• Bristol-Myers Squibb Company

• Other Prominent Players

What does the Antipsychotic Drugs Market Report Include?

The Antipsychotic Drugs Market report includes quantitative and qualitative analysis of several factors such as the key drivers and restraints that will impact growth. Additionally, the report provides insights into the regional analysis that covers different regions, which are contributing to the growth of the market. It includes the competitive landscape that involves the leading companies and the adoption of strategies by them to introduce new products, announce partnerships, and collaboration that will further contribute to the growth of the market between 2020 and 2026. Moreover, the research analyst has adopted several research methodologies such as PESTEL and SWOT analysis to extract information about the current trends and industry developments that will drive the market growth in the forthcoming years.

Highlights of the report:

• Detailed information on the latest industry trends, opportunities and challenges

• In-depth analysis of the drivers and barriers to growth

• Competitive landscape made up of investments, agreements, contracts, new product launches, strategic collaborations and mergers and acquisitions

• List of segments and niche areas

• Full details on the strategies adopted by the main players

With tables and figures helping analyze global Antipsychotic Drugs Market trends, this research provides key statistics on the state of the industry and is a valuable source of advice and guidance for businesses and individuals interested in the Market.

Driving Factor

Indivior, Otsuka, Allergan and Other Market Players Receive Fast Track Approvals

Fortune Business Insights has listed a few key developments that have occurred in the global antipsychotic drugs market since the past few years:

Indivior PLC, a specialty pharmaceuticals business based in the U.K., declared in July 2018 that it received FDA approval for Perseris, a long-acting injectable (LAI) containing risperidone. It is used to treat schizophrenia in adults. Perseris uses the extended-release delivery system that provides a certain level of risperidone which sustains over a month. According to the company, the FDA approval will support adult patients and their healthcare providers by providing a technologically advanced treatment option.

Otsuka Pharmaceutical Co., Ltd., a pharmaceutical company, headquartered in Tokyo, announced the launch of Rexulti in Japan in April 2018. Rexulti is available in both 1mg and 2mg variants for the treatment of schizophrenia. It is already available in the pharmacies in Australia, Canada, and the U.S.

The efficacy and safety of Rexulti were examined in four clinical phase III studies that were controlled by placebo. The tablets were superior for the treatment of schizophrenia when provided at specific dosages. Otsuka recommends giving the patients a lower dose during the initial treatment procedure and then slowly increase the dosage over time. They are to be consumed regularly with or without meals.

Allergan, a pharmaceutical company based in Ireland, declared that the FDA approved Vraylar in May 2019. As per the approval, Vraylar can now be used in the treatment of depressive episodes that are associated with bipolar depression (bipolar I disorder) in adult patients. In the U.S., Vraylar can also be used to treat manic episodes occurring due to bipolar I disorder.

Research Methodology:

We follow a robust research methodology that involves data triangulation based on top-down, bottom-up approaches, and validation of the estimated market numbers through primary research. The information used to estimate the market size and forecast for various segments at the global, regional, and country-level is derived from the most credible published sources and through interviews with the right stakeholders.

The Growth rate or CAGR exhibited by a market for a certain forecast period is calculated on the basis of various factors and their level of impact on the market. These factors include market drivers, restraints, industry challenges, market and technological developments, market trends, etc.

Key Questions Answered in the Report

• What is the expected global Antipsychotic Drugs Market size in terms of value during the period 2022-2028?

• What is the expected future scenario and revenue to be generated by different types of solutions including software and platform, hardware, and support services?

• Which region is the largest market for the global Antipsychotic Drugs Market?

• What is the expected future scenario and revenue to be generated by different regions and countries in the global precision agriculture market such as North America, South America, Europe, the U.K., China, Asia-Pacific and Japan, and Middle East and Africa?

• What is the competitive strength of the key players in the global Antipsychotic Drugs Market based on the analysis of their recent developments, product offerings, and regional presence?

• Which are the different consortiums and associations present in the worldwide Antipsychotic Drugs Market, and what are their roles, focus areas, and key functions in this market?

• Where do the key Antipsychotic Drugs Market companies lie in their competitive benchmarking, compared on basis of market coverage and market potential?

About Us:

Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. Our aim is to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.